Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood
- 4 March 2003
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 17 (8) , 757-766
- https://doi.org/10.1002/rcm.976
Abstract
Four glutathione (GSH) conjugates and two thiols were detected when depsipeptide FK228, formerly FR901228, a naturally occurring potent histone deacetylase (HDAC) inhibitor, was incubated in rat or human plasma in the presence of GSH. Their structures were elucidated by the high-performance liquid chromatography/electrospray ionization multi-stage mass spectrometry (HPLC/ESI-MSn) technique, and in some cases confirmed by accurate mass measurement. These products were also detected in rat and human blood homogenates following their incubation with FK228, but were not detected in GSH solution alone. A possible scheme for its formation is proposed. One of the thiols has recently been found to be more active as a histone deacetylase inhibitor than the parent compound. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 7 references indexed in Scilit:
- A subnanogram API LC/MS/MS quantitation method for depsipeptide FR901228 and its preclinical pharmacokineticsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cellsBreast Cancer Research and Treatment, 1998
- FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase InhibitorExperimental Cell Research, 1998
- Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MSInvestigational New Drugs, 1997
- Action of FR901228, a Novel Antitumor Bicyclic Depsipeptide Produced byChromo-bacterium violaceumNo. 968, on Ha-rasTransformed NIH3T3 CellsBioscience, Biotechnology, and Biochemistry, 1994
- FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice.The Journal of Antibiotics, 1994
- FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.The Journal of Antibiotics, 1994